About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » News » Drug News » Natco Pharma Commences Production At Dehradun Unit

Natco Pharma Commences Production At Dehradun Unit

by Medindia Content Team on Jun 27 2006 2:56 PM

Natco Pharma Ltd today said it has commenced commercial production at its Dehradun unit.

The company informed the Bombay Stock Exchange that the finished dosage pharmacuetical formulations unit would achieve a capacity level of 300 million tablets per annum and the project is being implemented in stages.

Plans of establishing a parenterals division at Dehradun are also underway, it added.

The share of the company was trading at Rs 102.35, down 4.48 per cent on the BSE.

Source:PTI News

Recommended Readings

Drug Toxicity

Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a drug, reaction to a drug or drug abuse.

Latest Drug News

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

The US FDA approves a immunotherapy drug, N-803, for BCG-unresponsive non-muscle invasive bladder cancer, suggested to be used in conjunction with BCG.

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

The increasing trend in strategic partnerships between innovator companies, and the US FDA approval for Rezdiffra has led to a boost in the development of medications for MASH.

Semaglutide: A Dominant Player for Patients With Heart Failure

Semaglutide: A Dominant Player for Patients With Heart Failure

Data provesSemaglutideefficacy in treatment of Type 2 diabetes, obesity, heart failure, and chronic kidney failure, it emerges as important therapy in metabolic syndrome.

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Generics are not widely used, despite cost advantage, due to a lack of information to patients and reluctance from physicians to prescribe generics - A Need to educate masses

Drug Resistant Melanoma Caused Due to Break in Genes!

Drug Resistant Melanoma Caused Due to Break in Genes!

Studies have led to discovery that drug-resistant melanomas are caused by breaks in the genes, thereby leading to emphasis on alternate targeted therapies to combat cancer.

Advertisement